Iron Dextran
- Generic Name
- Iron Dextran
- Brand Names
- Infed, Irospan 24/6 Kit
- Drug Type
- Small Molecule
- CAS Number
- 9004-66-4
- Unique Ingredient Identifier
- 95HR524N2M
- Background
Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible.
- Indication
For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.
- Associated Conditions
- Iron Deficiency (ID)
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury
- Conditions
- Anemia, Iron DeficiencyAcute Kidney Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-07-25
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Hospital Civil de Guadalajara
- Target Recruit Count
- 120
- Registration Number
- NCT05960227
- Locations
- 🇲🇽
Jonathan Samuel Chávez Iñiguez, Guadalajara, Jalisco, Mexico
🇲🇽Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
Practical Anemia Bundle for SusTained Blood Recovery
- Conditions
- Critical IllnessAnemia
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT05167734
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
- Conditions
- Anemia, Iron DeficiencyDelivery Complication
- Interventions
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-08-29
- Target Recruit Count
- 40
- Registration Number
- NCT05047211
- Locations
- 🇺🇸
Ashley Salazar, Galveston, Texas, United States
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
- Conditions
- Iron MalabsorptionIron Deficiency Anemia of Pregnancy
- Interventions
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 38
- Registration Number
- NCT03438227
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸Center for Outpatient Health, Washington University in St. Louis, Saint Louis, Missouri, United States
Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 66
- Registration Number
- NCT03212781
- Locations
- 🇪🇬
Assiut Faculty of Medicine, Assiut, Egypt
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 161
- Registration Number
- NCT00704028
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Norristown, Pennsylvania, United States
Trial Comparing the Safety of Two Different Intravenous Iron Formulations
- Conditions
- Iron Deficiency AnemiaPerioperative Blood Conservation
- Interventions
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2009-03-03
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 200
- Registration Number
- NCT00593619
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.